An Open-label Extension Study of PSMA ADC 2301 in mCRPC
Clinical trial NCT02020135 · COMPLETED
Trial details
- NCT number
- NCT02020135
- Sponsor
- Progenics Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-02-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.